Order Article Reprints

Gascón M, Isla D, Cruellas M, Gálvez EM, Lastra R, Ocáriz M, Paño JR, Ramírez A, Sesma A, Torres-Ramón I, et al. Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One? Cells. 2020; 9(6):1525. https://doi.org/10.3390/cells9061525

Gascón, Marta, Dolores Isla, Mara Cruellas, Eva M. Gálvez, Rodrigo Lastra, Maitane Ocáriz, José Ramón Paño, Ariel Ramírez, Andrea Sesma, Irene Torres-Ramón, and et al. 2020. "Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?" Cells 9, no. 6: 1525. https://doi.org/10.3390/cells9061525

Gascón, M., Isla, D., Cruellas, M., Gálvez, E. M., Lastra, R., Ocáriz, M., Paño, J. R., Ramírez, A., Sesma, A., Torres-Ramón, I., Yubero, A., Pardo, J., & Martínez-Lostao, L. (2020). Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One? Cells, 9(6), 1525. https://doi.org/10.3390/cells9061525